GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ADC · Mar 31, 2025

AGREE REALTY CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001558370-25-005142Reit

Operating-cash-flow growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.operating_cash_flow

22.80% · OPTIONAL · NOT_ENOUGH_HISTORY

Net-income growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.net_income

4.76% · CORE · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

13.19% · CORE · NOT_ENOUGH_HISTORY

Cash and equivalentsRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.cash

$7.9M · CORE · NOT_ENOUGH_HISTORY

Operating-income growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.operating_income

11.63% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History2 statesHistory building

Mar 31, 20250/5 normalizedLevel 3 Sep 30, 20261/5 normalizedLevel 3

Period transition

What moved in the state?

Liquidity Increased

Previous: $6.4M
Current: $7.9M
Delta: $1.5M

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · ADC Fundamental State →Has State · AGREE REALTY CORP →Transitioned To · ADC LIQUIDITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.